|
FY2025
12 months to Sep 27, 2025
|
FY2024
12 months to Sep 28, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Oct 1, 2022
|
FY2021
12 months to Oct 2, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Inventory write-down | |||||
| Gross profit | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Interest | |||||
| Asset Impairment Charges | |||||
| Restructuring | |||||
| Loss on sale of businesses | |||||
| Gain on sale of buildings | |||||
| Pension settlement | |||||
| Other | |||||
| Earnings before income taxes | |||||
| Income taxes | |||||
| Net earnings | |||||
| Net earnings per share | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average common shares outstanding | |||||
| Basic | |||||
| Diluted |
Loading...